2026-02-18, 2:04:40 p.m.
BEDFORD, Mass. — February 18, 2026 — Leads & Copy — Anika Therapeutics, Inc. (NASDAQ: ANIK) announced that President and CEO Steve Griffin will present at the Canaccord Genuity 2026 Musculoskeletal Conference in New Orleans on Monday, March 2, 2026, at 11:30 a.m. CT / 12:30 p.m. ET.
Management will also participate in one-on-one investor meetings during the conference.
The presentation will be webcast live on the Events and Webcasts page under the Investors section of Anika Therapeutics’ website and archived for 30 days. Contact Anika’s Investor Relations at investorrelations@anika.com for details or to schedule a meeting with senior management.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global joint preservation company focused on advancements in early intervention orthopedic care. It uses expertise in hyaluronic acid and implant solutions and partners with clinicians to deliver minimally invasive products. The company focuses on high-opportunity areas within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, efficiently delivered in ambulatory surgery centers.
Anika’s global operations are based outside of Boston, Massachusetts. ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc.
Source: Anika Therapeutics, Inc.
